Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.

  • Ewa Grzybowska Department of Tumor Biology, Centre of Oncology-Maria Skłodowska-Curie Memorial Institute, Gliwice, Poland. ewagrzybo@yahoo.com;
  • Marzena Siemińska
  • Helena Zientek
  • Ewa Kalinowska
  • Jadwiga Michalska
  • Beata Utracka-Hutka
  • Jadwiga Rogozińska-Szczepka
  • Maria Kaźmierczak-Maciejewska

Abstract

Germline mutations in the BRCA1 or BRCA2 genes predispose their carriers to breast or/and ovary cancers during their lifetime. The most frequent mutations: 5382insC, 185delAG, C61G and 4153delA in BRCA1, and 6174delT and 9631delC in BRCA2 were studied in a group of 148 probands admitted for genetic counseling, using allele-specific amplification (ASA) PCR test. Fifteen carriers of three different mutations: 5382insC, 185delAG and C61G in BRCA1 were found. Two families carried the 185delAG mutation and additional two C61G in BRCA1. Nobody carried the mutation 4153delA in BRCA1 nor 6174delT or 9631delC in BRCA2. Most of the carriers of a germline mutation were observed among the patients who developed bilateral breast cancer (17%). The lowest frequency of the germline mutations was found in the healthy persons who had two or more relatives affected with breast or ovarian cancer.
Published
2002-06-30
Section
Articles